Instrument Inactif

Communiqués Opsens Inc.

Actions

OPS

CA6838231083

Communiqués

Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !

HAEMONETICS COMPLETES ACQUISITION OF OPSENS	12/12	AQ
OPSENS RECEIVES FINAL ORDER FOR ARRANGEMENT WITH HAEMONETICS	08/12	AQ
OPSENS' SHAREHOLDERS APPROVE ARRANGEMENT WITH HAEMONETICS	01/12	AQ
OPSENS OBTAINS REGULATORY CLEARANCE OF ARRANGEMENT IN THE UNITED STATES AND CANADA; REGULATORY APPROVALS CONDITION SATISFIED	28/11	AQ
Opsens : Management’s Discussion & analysis for the year 2023	22/11	PU
OPSENS ANNOUNCES FOURTH QUARTER AND FISCAL YEAR 2023 FINANCIAL RESULTS	22/11	AQ
INDEPENDENT PROXY ADVISORY FIRM ISS RECOMMENDS SHAREHOLDERS VOTE "FOR" OPSENS INC. PLAN OF ARRANGEMENT WITH HAEMONETICS CORPORATION	13/11	AQ
OPSENS RECEIVES INTERIM ORDER AND FILES MANAGEMENT INFORMATION CIRCULAR IN CONNECTION WITH SPECIAL MEETING OF SHAREHOLDERS	02/11	AQ
OPSENS ANNOUNCES THE POSITIVE CLINICAL RESULTS FROM THE SAFE-TAVI STUDY WITH SAVVYWIRE IN EUROPE	23/10/23	AQ
OpSens to Participate in the Transcatheter Cardiovascular Therapeutics Conference (TCT) in San Francisco October 23 - 26, 2023	17/10/23	AQ
OPSENS SIGNS DEFINITIVE AGREEMENT FOR ITS ACQUISITION BY HAEMONETICS	10/10/23	AQ
OPSENS ANNOUNCES A THIRD CONSECUTIVE QUARTER OF RECORD REVENUES FOR THIRD QUARTER FISCAL 2023	13/07/23	AQ
OPSENS TO HOST THIRD QUARTER FISCAL YEAR 2023 FINANCIAL RESULTS CONFERENCE CALL ON THURSDAY JULY 13, 2023	06/07/23	AQ
Opsens : Interim Consolidated Financial Statements for the nine-month period ended May 31, 2023	06/07/23	PU
OPSENS ANNOUNCES INCLUSION OF SAVVYWIRE™ IN COMPLETE TAVR STUDY	10/05/23	AQ
OpSens Announces Participation in the 2023 Bloom Burton & Co. Healthcare Investor Conference	20/04/23	NE
OPSENS ANNOUNCES RECORD REVENUE FOR SECOND QUARTER FISCAL 2023	13/04/23	AQ
OPSENS ANNOUNCES COMPLETION OF ENROLLMENT IN SAFE-TAVI STUDY WITH SAVVYWIRE® IN EUROPE	11/04/23	AQ
OPSENS TO HOST SECOND QUARTER FISCAL YEAR 2023 FINANCIAL RESULTS CONFERENCE CALL ON THURSDAY APRIL 13, 2023	06/04/23	AQ
OPSENS ANNOUNCES 1,000TH SAVVYWIRE PROCEDURE	05/04/23	AQ

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Communiqués Opsens Inc.

Actions

OPS

CA6838231083

Communiqués

Filtres